Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 19011222)

1.

Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.

Jenq RR, King CG, Volk C, Suh D, Smith OM, Rao UK, Yim NL, Holland AM, Lu SX, Zakrzewski JL, Goldberg GL, Diab A, Alpdogan O, Penack O, Na IK, Kappel LW, Wolchok JD, Houghton AN, Perales MA, van den Brink MR.

Blood. 2009 Feb 12;113(7):1574-80. doi: 10.1182/blood-2008-05-155697. Epub 2008 Nov 14.

2.

Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation.

Min D, Taylor PA, Panoskaltsis-Mortari A, Chung B, Danilenko DM, Farrell C, Lacey DL, Blazar BR, Weinberg KI.

Blood. 2002 Jun 15;99(12):4592-600.

3.

Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation.

Kelly RM, Highfill SL, Panoskaltsis-Mortari A, Taylor PA, Boyd RL, Holländer GA, Blazar BR.

Blood. 2008 Jun 15;111(12):5734-44. doi: 10.1182/blood-2008-01-136531. Epub 2008 Mar 11.

4.

Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.

Kelly RM, Goren EM, Taylor PA, Mueller SN, Stefanski HE, Osborn MJ, Scott HS, Komarova EA, Gudkov AV, Holländer GA, Blazar BR.

Blood. 2010 Feb 4;115(5):1088-97. doi: 10.1182/blood-2009-05-223198. Epub 2009 Dec 4.

5.

Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant.

Wang Y, Chen G, Qiao S, Ma X, Tang X, Sun A, Wu D.

Leuk Lymphoma. 2011 Aug;52(8):1556-66. doi: 10.3109/10428194.2011.573037. Epub 2011 Jun 8.

PMID:
21649545
6.

Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow-bone marrow transplantation plus fetal thymus transplantation.

Hosaka N, Cui W, Zhang Y, Takaki T, Inaba M, Ikehara S.

Cancer Immunol Immunother. 2010 Jul;59(7):1121-30. doi: 10.1007/s00262-010-0840-2. Epub 2010 Mar 13.

PMID:
20229083
7.

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.

Alpdogan O, Eng JM, Muriglan SJ, Willis LM, Hubbard VM, Tjoe KH, Terwey TH, Kochman A, van den Brink MR.

Blood. 2005 Jan 15;105(2):865-73. Epub 2004 Jul 27.

9.

Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.

Bruinsma M, van Soest PL, Leenen PJ, Löwenberg B, Cornelissen JJ, Braakman E.

J Immunol. 2009 Jun 15;182(12):7364-9. doi: 10.4049/jimmunol.0803253.

10.

Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury.

Panoskaltsis-Mortari A, Taylor PA, Rubin JS, Uren A, Welniak LA, Murphy WJ, Farrell CL, Lacey DL, Blazar BR.

Blood. 2000 Dec 15;96(13):4350-6.

11.

Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, Rotolo JA, Halm JA, Rich BE, van den Brink MR.

Blood. 2001 Oct 1;98(7):2256-65.

12.

Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.

Teshima T, Mach N, Hill GR, Pan L, Gillessen S, Dranoff G, Ferrara JL.

Cancer Res. 2001 Jan 1;61(1):162-71.

13.

Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration.

Alpdogan O, Hubbard VM, Smith OM, Patel N, Lu S, Goldberg GL, Gray DH, Feinman J, Kochman AA, Eng JM, Suh D, Muriglan SJ, Boyd RL, van den Brink MR.

Blood. 2006 Mar 15;107(6):2453-60. Epub 2005 Nov 22.

14.
15.

Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects.

Miyake T, Hosaka N, Cui W, Nishida T, Takaki T, Inaba M, Kamiyama Y, Ikehara S.

Immunology. 2009 Apr;126(4):552-64. doi: 10.1111/j.1365-2567.2008.02920.x. Epub 2008 Sep 4.

16.

Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output.

Bruinsma M, van Soest PL, Leenen PJ, Lambrecht BN, Cupedo T, Löwenberg B, Cornelissen JJ, Braakman E.

J Immunol. 2007 Dec 1;179(11):7424-30.

17.

Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.

Clouthier SG, Cooke KR, Teshima T, Lowler KP, Liu C, Connolly K, Ferrara JL.

Biol Blood Marrow Transplant. 2003 Sep;9(9):592-603.

PMID:
14506661
18.

Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.

Hossain MS, Roback JD, Lezhava L, Hillyer CD, Waller EK.

Biol Blood Marrow Transplant. 2005 Mar;11(3):169-80.

PMID:
15744235
19.

Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7.

Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K.

Blood. 1996 Sep 1;88(5):1887-94.

20.

[Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].

Cao J, Li L, Chen C, Zeng LY, Li ZY, Pan XY, Xu KL.

Zhonghua Xue Ye Xue Za Zhi. 2011 Feb;32(2):83-8. Chinese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk